Including the Patient Perspective in Health Care Decision Making

Published Nov 8, 2017
Glasgow, Scotland, UK—8 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), held a number of sessions focused on patient engagement at its 20th Annual European Congress in Glasgow, Scotland, UK. Patient-Powered Registries On 6 November, a workshop on “Patient-Powered Registries: Useful for Health Technology Assessment or Not?” [W2] was held. Discussion leaders included, Gurmit Sandhu, B Pharm (Hons), MBA, MPH, Gurmit Sandhu Consulting GmbH, Basel, Switzerland; Elisabeth M. Oehrlein, BA, University of Maryland School of Pharmacy, Baltimore, MD, USA; Robert N. McBurney, PhD, Accelerated Cure Project for MS, Waltham, MA, USA; and Chantal Guilhaume, PharmD, Haute Autorité de Santé, Saint-Denis La Plaine, France. Patient-powered registries provide an emerging data source that collect information directly from patients on a specific disease or condition. Speakers discussed the possible applications of patient-powered registries to health technology assessment bodies. Patient-Centered Decision Making On 7 November an issue panel, “Patient-Centered Decision Making: How Do You Generate Relevant Patient-Reported Outcomes Evidence for Chronic Disease Management and Market-Access Decision Making?” [IP14], was held. The moderator for the panel was Finn Børlum Kristensen, MD, PhD, University of Southern Denmark, Hilleroed, Denmark. Panelists included, Katharine Barnard, PhD CPsychol AFBPsS, Bournemouth University, Poole, UK; Simon O'Neill, REG.N., Diabetes UK, London, UK; and Francois Meyer, PhD, Haute Autorité de Santé, Saint-Denis, France. The panel discussed the practical aspects of generating and synthesizing patient-reported outcomes, considering that their use in health care decisions can be controversial. Incorporating the Patient Voice in the NICE Process On 8 November an issue panel was held that discussed, “Can the Patient Voice Be Better Incorporated Into the National Institute for Health and Care Excellence (NICE) Process?” [IP19]. The panel was moderated by Eric Low, NA, formerly of Myeloma UK, East Lothian, UK. Panelists included Jennifer Lee, MBA, Janssen UK, High Wycombe, UK; Heidi Livingstone, BA, NICE, London, UK; and Richard Jackson, PGCE, NPQH, a patient expert in the UK. Most global health technology assessment bodies have not yet formalized how patients have input in health care decision making. The panel discussed how the recent NICE consultation on public and patient input may offer an opportunity to increase patient engagement in the NICE process. Incorporating the Patient Perspective Into Health Technology Assessments On 8 November an issue panel entitled, “How Do You Incorporate the Patient Perspective Into Health Technology Assessments? Defining Best Practices for Rigorous Scientific Evidence and Impactful Submissions and Reviews” [IP23] was held. Judith Leah Rubinstein, MIA, Context Matters Inc., New York, NY, USA moderated the panel. Panelists included Paola Kruger, MA, Accademia dei Pazienti/EUPATI Italia, Rome, Italy; Ken Bond, MA, CADTH, Ottawa, ON, Canada; and Laure Delbecque, PhD, Pharmerit International, Rotterdam, The Netherlands. Increasingly, health technology assessment (HTA) bodies are seeking to include patients as key stakeholders in the HTA review process. Currently, however, no standard methods to obtain patients’ perspectives are agreed upon. This lack of a standardized method for data collection results in evidence that may be anecdotal, not meaningful, or difficult to interpret. The panel, representing a variety of perspectives, discussed the quality and value of patient testimonials as evidence. The Society has a number of initiatives centered on patient involvement in health care decision making. ISPOR’s Patient Representative Roundtables, held in Europe, North America, Latin America, and Asia-Pacific, seek to provide a platform for patient representatives to interact with other health care stakeholders and to determine how best to engage patients in the research and decision making processes. The ISPOR Patient Centered Special Interest Group works to facilitate the involvement of patient representatives in all stages of research and decision making to improve health care, its delivery, and outcomes. Additional information on the ISPOR 20th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the congress on social media using the hashtag #ISPORGlasgow.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

Cracking the Code on Medicare's Drug Price Negotiations

Oct 1, 2024

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.

ISPOR Europe 2024 Plenaries and Speakers Announced

Sep 23, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for ISPOR Europe 2024. The conference is the leading European conference for health economics and outcomes research (HEOR) and is scheduled for 17-20 November in Barcelona, Spain with the theme, “Generating Evidence Toward Health and Well-Being.”

ISPOR Announces New Strategic Plan 2030

Jul 29, 2024

ISPOR announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×